Tea polyphenols

About us
Green tea extract
civilization of tea
Herb extract
Biochemistry products
Chinese herb
Material base
Equipment
E-shopping
corona-fz@263.net
Chinese
BIG5

 

DOSAGE OF THE CHINESE ANTICANCER HERBAL

PART A PART B PART C
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pingying: Xuanshen
English: Ningpo Figwort
Latin: Scropularia ningpoensis Hemis

Sources:The roots of Scropularia ningpoensis Hemis. Family Sorophulariaceae.

Constituents: Containing scrophularin, iridoid harpagoside being 70%~80% of the iridois, volatile oil, volatile alkaloid, glucosides, L-asparagine, fatty acid, etc.

Actions:
500ug/ml water extract of the herb has 50%~70% inhibiting rates against human cerviacl carcinoma JTC-26 cell line.

Indications:It was used for treatment of esophageal, nasopharyngeal, colonic carcinoma and lymphoma, thyroid adenocarcinoma, etc.

(1) Composite prescription for esophageal cancer:
Radix Scrophulariae 15g
Radix Rehmanniae 13g
Radix Ophiopogonis 15g
Radix Adenophorae 15g
Gypsum Fibrosum 60g
Fructus Forsythiae 10g
Semen Persicae 10g
Cortex Moutan 10g
Radix Glycyrrhizae 10g
Flos Lonicerae 10g

The decoction of above herbs was taken to treat radiotherapeutic reactions of the patients suffering from esophageal cancer (42 cases).

The clinical results showed that remarkable effect (symptom disappeard or basically disappeared, patient's general condition turned better), and improvement (symptom vanished, the condition improved) were 29 and 9 cases respectively, the total effective rate was 90.4%.

(2) Composite prescription for nasopharyngeal carcinoma:
Radix Scrophulariae 30g
Radix Glehniae 30g
Radix Ophiopogonis 15g
Fructus Ligustri Lucidi 15g
Fructus Xanthii 15g
Flos Magnoliae 15g
Radix Angelicae Dahuricae 15g
Semen Cuscutae 15g
Herba Selaginellae 15g
Radix Astragali 25g
Herba Dendrobii 25g
Rhizoma Atractylodis 25g
Macrocephalae
Radix Arnebiae 25g
Radix Sophorae TonRinensis 10g
Rhizoma Acori Tatarnowii 10g
Rhizoma Dioscoreae 10g
Rhizoma Anemarrhenae 12g

The formulas was used to treat 50 cases of nasopharyngeal carcinoma after radiotherapy, CR was in 12 cases. The survival rate above 5 years was 24%. The cases of CR, PR, MR and NC were 12.16, 4 and 6 respectively.

  
 

All Copy: FuZhou Corona Science & Technology Development Co.,Ltd.
Head Office Tel:  86-591-8376-9772 ;  8376-9751    Fax:  86-591-8376-9723
Copyright© 2001-2008 All right reserved